Table 2 Association between variables and metabolic syndrome
With MetSaN = 197 (46.2%) | Without MetS N = 229 (53.8%) | P value | |
|---|---|---|---|
Age | 65 | 63 | 0.007* |
BMI | 28 | 27 | < 0.001* |
Smoking | 0.037• | ||
Yes | 128 (30%) | 126 (29.6%) | |
No | 69 (16.2%) | 103 (24.2%) | |
IPSS score | 21 | 18 | < 0.001* |
IPSS severity | < 0.001• | ||
Mild (0–7) | 16 (3.8%) | 36 (8.5%) | |
Moderate (8–19) | 64 (15%) | 110 (25.8%) | |
Severe (20–35) | 117 (27.5%) | 83 (19.5%) | |
Prostate volume | 40 | 40 | 0.743* |
Q1 | 0.423• | ||
0 | 101 (23.7%) | 122 (28.6%) | |
1–2 | 6 (1.4%) | 12 (2.8%) | |
3–5 | 90 (21.1%) | 95 (22.3%) | |
Q2 | 0.013• | ||
0 | 78 (18.3%) | 122 (28.6%) | |
1–2 | 18 (4.2%) | 21 (4.9%) | |
3–5 | 101 (23.7%) | 86 (20.2%) | |
Q3 | 0.006• | ||
0 | 30 (7%) | 51 (12%) | |
1–2 | 2 (0.5%) | 12 (2.8%) | |
3–5 | 165 (38.7%) | 166 (39%) | |
Q4 | 0.068• | ||
0 | 57 (13.4%) | 90 (21.1%) | |
1–2 | 14 (3.3%) | 17 (4%) | |
3–5 | 126 (29.6%) | 122 (28.6%) | |
Q5 | 0.065• | ||
0 | 20 (4.7%) | 40 (9.4%) | |
1–2 | 6 (1.4%) | 10 (2.3%) | |
3–5 | 171 (40.1%) | 179 (42%) | |
Q6 | 0.955• | ||
0 | 81 (19%) | 96 (22.5%) | |
1–2 | 17 (4%) | 18 (4.2%) | |
3–5 | 99 (23.2%) | 115 (27%) | |
Q7 | < 0.001• | ||
0 | 4 (0.9%) | 12 (2.8%) | |
1–2 | 37 (8.7%) | 77 (18.1%) | |
3–5 | 156 (36.6%) | 140 (32.9%) |